ug discovery 4. Invest further in catalytic infrastructure to support dementia drug discovery beyond ChemCo, e.g. blood-brain-barrier technologies, iPSC banks, diagnostic technologies, novel clinical end points -* Larger DDF fund will enable discovery and development of many more than 2-3 novel drugs for